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177Lu and 153Sm are perspective radionuclides in terms of applying in nuclear med-
icine. High-energy beta particles and the relatively half-life of the radionuclide are used 
to achieve an effective palliative treatment of bone metastases. The technology-tar-
geted delivery of the radionuclide to the pathological area is used to minimize radiation 
exposure to healthy organs and tissues. This result is achieved by the rapid delivery of 
the radiopharmaceutical to the tumor cells. For example, different complexes are used 
for bones cancer treatment like 153Sm-EDTMP and 177Lu-EDTMP. This complex is 
concentrated in the skeleton in proportion to osteoblastic activity. Pathological foci, 
where the accumulation is intense, can be visualized in studies in the gamma camera 
which allows scintigraphy of the patient and monitor the treatment process. In this 
work, the effect of the drug carrier EDTMP (i.e. ethylene diamine tetramethylene phos-
phate) on the ionic form of 177Lu and 153Sm is presented. The absorbed doses in differ-
ent organs and tissues of 177Lu and 153Sm in ionic form and labelled with EDTMP are 
determined by IDAC-Dose 2.1 (Internal Dose Assessment by Computer) software. 
WinAct software is used to calculate cumulative activity1,2. 177Lu and 153Sm are lantha-
nide radionuclide which actively accumulates in the liver and bone when uses in ionic 
form. In the case of labelling with EDTMP, the distribution and elimination of the drug 
occur according to the kinetics of the carrier, (i.e. ethylene diamine tetramethylene 
phosphate). The using of osteotropic (Describing any drug etc. that is attracted to, and 
targets bone) complex allows creating a large dose in the pathological areas and mini-
mizing damages in healthy organs and tissues. 177Lu and 153Sm labelled with EDTMP 
are decreasing the liver dose absorption and increasing the bone surface absorption for 
more effective treatment and minimize side effect. The effective dose per administered 
activity was estimated to be 0.189 msv/mbq for 177Lu-ionic form, 0.232 mSv/MBq for 
153Sm-ionic form and 0.242 mSv/MBq for 177Lu-EDTMP and 0.139 mSv/MBq 
for153sm-EDTMP. Figure 1 shows the direct effect of EDTMP in absorbed dose distri-
bution for different organs and tissues. Also, even in ionic form the distribution of 177Lu 
is better than 153Sm more absorbed in bone surface, red bone marrow, and kidney with 







 Fig. 1. Absorbed Dose in (mSv/MBq) in different organs and tissues 
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Abstract. The purpose of the research was to investigate the potential of using SiO2-MnO2 
nanopowder, obtained by electron beam evaporation, as a drug delivery system. The evalua-
tion of the sedimentation stability of suspensions was conducted for further in vivo studies. It 
was established that PEG stabilized suspensions showed the highest stability. Drug loading 
and release experiments with nanopowders demonstrated a high drug loading capacity of 
Amoxicillin and Doxorubicin. 
 
Conventional drugs frequently exhibit high toxicity in healthy tissues that leads to 
reducing the injected dose because of increased risk of side effects, which seriously 
affects drug effectiveness during the therapeutic process [1]. Targeted drug delivery 
systems based on nanopowder (NP) can cope with these limitations. 
Among the diverse nano-carriers based on Fe, C, TiO2 and Au nanoparticles one of 
the most promising system for targeted drug delivery is SiO2 NP which potentially have 
high porosity and specific surface area, the possibility of varying pore sizes, good 
